Time Trends in Ovarian Cancer Survival in Estonia by Age and Stage.

Int J Gynecol Cancer

*Oncology Centre, East Tallinn Central Hospital, Tallinn; †Faculty of Medicine, Tartu University, Tartu; ‡Women's Clinic, West Tallinn Central Hospital; §Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn; and ∥Haematology-Oncology Clinics, Tartu University Hospital, Tartu, Estonia.

Published: January 2017

AI Article Synopsis

  • - The study aimed to analyze ovarian cancer survival trends in Estonia from 1995 to 2009, assessing the impact of age and disease stage on survival rates.
  • - Data from the Estonian Cancer Registry indicated that the 5-year relative survival ratio for ovarian cancer improved from 27% to 38% over the years studied, especially for women aged 50 to 69.
  • - Although survival rates increased across all age and stage groups, the progress was slower for older women, raising concerns about their outcomes compared to younger patients and those diagnosed at earlier stages.

Article Abstract

Objective: The objective of the study was to examine temporal trends in ovarian cancer (OC) survival in Estonia during 1995 to 2009 in relation to age and stage.

Materials And Methods: Estonian Cancer Registry data on all adult cases of primary OC diagnosed during 1995 to 2009 and followed up for vital status until 2014 were used to estimate relative survival ratios (RSRs). Cohort analysis was used to estimate 1-, 2-, and 5-year RSRs for patients diagnosed in 1995 to 1999, 2000 to 2004, and 2005 to 2009. Analysis was performed by age at diagnosis (<50; 50-59; 60-69; 70+ years) and stage (International Federation of Gynecology and Obstetrics 1988).

Results: Among 2296 women included in the study, the age-adjusted 5-year RSR improved from 27% in 1995 to 1999 to 38% in 2005 to 2009. Survival increase of 10% units from 1995 to 1999 to 2005 to 2009 was seen for women aged 50 to 59 and 60 to 69 years. Among younger and older women, the respective changes were smaller. In 1995 to 1999, the difference in survival between the youngest and oldest age groups was 41% units. This decreased over the study period to 37% units. From 1995 to 1999 to 2005 to 2009, the 5-year RSR increased from 82% to 91% for stage I patients; from 48% to 67% for stage II patients; from 25% to 35% for stage III patients; and from 11% to 16% for stage IV patients.

Conclusions: The study showed an improvement of OC survival in Estonia in all age and stage groups, but particularly among younger women and those with early stage disease. Slower progress among older women is of great concern.

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000858DOI Listing

Publication Analysis

Top Keywords

trends ovarian
8
ovarian cancer
8
cancer survival
8
survival estonia
8
1995 2009
8
diagnosed 1995
8
time trends
4
estonia age
4
age stage
4
stage objective
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!